Detecting Cardiomyocyte Arrhythmia

Detecting Cardiomyocyte Arrhythmia

The development of cardiac arrhythmias as an unintended pharmacological side effect is the most common cause of drug withdrawal and restrictions placed on marketed drugs. CDI’s cardiomyocytes have emerged as the most physiologically relevant and predictive human in vitro model system for detecting drug-mediated arrhythmias. Researchers have demonstrated the utility of these cardiomyocytes for this application using platforms including: